[New analysis of CAPRIE (Clopidogrel vs Aspirin in Patients at Risk of Ischemic Events) shows: myocardial infarct most effectively prevented in the clopidogrel group].
D000077144:Clopidogrel; D006801:Humans; D017202:Myocardial Ischemia / Q000517:prevention & control*; D010919:Placebos; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D012307:Risk Factors; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*
D010919:Placebos; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine
Neue Analyse von CAPRIE zeigt: Herzinfarkte in der Clopidogrel-Gruppe am effektivsten verhindert.